NASDAQ:MACK - Merrimack Pharmaceuticals Price Target & Analyst Ratings

$5.65
-0.09 (-1.57 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
$5.50
Now: $5.65
$5.69
50-Day Range
$5.72
MA: $6.00
$6.68
52-Week Range
$3.34
Now: $5.65
$9.85
Volume26,000 shs
Average Volume68,693 shs
Market Capitalization$75.39 million
P/E RatioN/A
Dividend YieldN/A
Beta2.28

Analyst Ratings

Merrimack Pharmaceuticals (NASDAQ:MACK) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Merrimack Pharmaceuticals in the last 12 months. Their average twelve-month price target is $4.00, suggesting that the stock has a possible downside of 29.20%. The high price target for MACK is $4.00 and the low price target for MACK is $4.00. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.671.671.671.67
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.00$4.00$4.00$4.00
Price Target Upside: 29.20% downside15.79% downside15.79% downside15.79% downside

Merrimack Pharmaceuticals (NASDAQ:MACK) Consensus Price Target History

Price Target History for Merrimack Pharmaceuticals (NASDAQ:MACK)

Merrimack Pharmaceuticals (NASDAQ:MACK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/7/2018CowenReiterated RatingHoldMediumView Rating Details
10/20/2018Robert W. BairdSet Price TargetNeutral ➝ Hold$7.00 ➝ $4.00HighView Rating Details
6/25/2018JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightHighView Rating Details
(Data available from 6/17/2017 forward)
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel